BeOne Medicines (ONC) Total Liabilities (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Total Liabilities data on file, last reported at $3.8 billion in Q1 2026.

• Quarterly Total Liabilities rose 61.96% year-over-year to $3.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 billion (up 61.96% YoY) and the FY2025 annual result came in at $3.8 billion, up 47.85% from the prior year.
• Total Liabilities slipped to $3.8 billion in Q1 2026 per ONC's latest filing, from $3.8 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $3.8 billion in Q4 2025 and bottomed at $1.1 billion in Q4 2022.
• The 5-year median for Total Liabilities is $2.3 billion (2024), against an average of $2.4 billion.
• The widest annual swing landed in 2022, when Total Liabilities plunged 54.31%; it then soared 106.59% in 2023.
• Tracing ONC's Total Liabilities over 5 years: stood at $1.1 billion in 2022, then jumped by 106.59% to $2.3 billion in 2023, then climbed by 14.14% to $2.6 billion in 2024, then soared by 47.85% to $3.8 billion in 2025, then retreated by 0.89% to $3.8 billion in 2026.
• Per Business Quant, the three latest ONC Total Liabilities figures stand at $3.8 billion (Q1 2026), $3.8 billion (Q4 2025), and $3.5 billion (Q3 2025).

Peer Comparison